Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
J Clin Oncol. 2023 Jul 1;41(19):3534-3544. doi: 10.1200/JCO.22.01935. Epub 2023 May 1.
J Clin Oncol. 2023.
PMID: 37126762
Free PMC article.
Clinical Trial.
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes.
Koutsavlis I.
Koutsavlis I.
Anemia. 2016;2016:8494738. doi: 10.1155/2016/8494738. Epub 2016 Apr 19.
Anemia. 2016.
PMID: 27195147
Free PMC article.
Review.
Item in Clipboard
The rare green-blue neutrophil inclusion bodies. Worth reporting in blood films? A case of a patient with polytrauma.
Bowen RK, Koutsavlis I.
Bowen RK, et al. Among authors: koutsavlis i.
Clin Case Rep. 2020 Jul 16;8(12):3549-3550. doi: 10.1002/ccr3.3105. eCollection 2020 Dec.
Clin Case Rep. 2020.
PMID: 33363972
Free PMC article.
Item in Clipboard
Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn.
Koutsavlis I.
Koutsavlis I.
Ann Hematol. 2021 Jan;100(1):1-10. doi: 10.1007/s00277-020-04294-x. Epub 2020 Oct 3.
Ann Hematol. 2021.
PMID: 33009935
Review.
Item in Clipboard
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.
Claudiani S, Chee L, Fernando F, Brown L, Achandira UM, Khan A, Rothwell K, Hayden C, Koutsavlis I, Hannah G, Innes A, Apperley JF, Milojkovic D.
Claudiani S, et al. Among authors: koutsavlis i.
Am J Hematol. 2024 Jun;99(6):1172-1174. doi: 10.1002/ajh.27278. Epub 2024 Mar 4.
Am J Hematol. 2024.
PMID: 38436141
Item in Clipboard
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Carreño-Tarragona G, Álvarez-Larrán A, Harrison C, Martínez-Ávila JC, Hernández-Boluda JC, Ferrer-Marín F, Radia DH, Mora E, Francis S, González-Martínez T, Goddard K, Pérez-Encinas M, Narayanan S, Raya JM, Singh V, Gutiérrez X, Toth P, Amat-Martínez P, Mcilwaine L, Alobaidi M, Mayani K, McGregor A, Stuckey R, Psaila B, Segura A, Alvares C, Davidson K, Osorio S, Cutting R, Sweeney CP, Rufián L, Moreno L, Cuenca I, Smith J, Morales ML, Gil-Manso R, Koutsavlis I, Wang L, Mead AJ, Rozman M, Martínez-López J, Ayala R, Cross NCP.
Carreño-Tarragona G, et al. Among authors: koutsavlis i.
Blood Adv. 2023 May 9;7(9):1672-1681. doi: 10.1182/bloodadvances.2022008204.
Blood Adv. 2023.
PMID: 36375042
Free PMC article.
Item in Clipboard
Progressive multifocal leukoencephalopathy following five lines of therapy and three autologous bone marrow transplants for multiple myeloma.
Knight K, Chien S, Koutsavlis I, Campbell V.
Knight K, et al. Among authors: koutsavlis i.
BMJ Case Rep. 2020 Mar 22;13(3):e233552. doi: 10.1136/bcr-2019-233552.
BMJ Case Rep. 2020.
PMID: 32205382
Free PMC article.
Item in Clipboard
Cite
Cite